Arcturus Therapeutics In... (ARCT)
NASDAQ: ARCT
· Real-Time Price · USD
19.48
0.25 (1.30%)
At close: Aug 15, 2025, 3:59 PM
19.70
1.10%
After-hours: Aug 15, 2025, 06:45 PM EDT
1.30% (1D)
| Bid | 18.88 |
| Market Cap | 529.11M |
| Revenue (ttm) | 135.17M |
| Net Income (ttm) | -68.2M |
| EPS (ttm) | -2.22 |
| PE Ratio (ttm) | -8.78 |
| Forward PE | -4.29 |
| Analyst | Buy |
| Ask | 19.7 |
| Volume | 822,592 |
| Avg. Volume (20D) | 517,441 |
| Open | 19.21 |
| Previous Close | 19.23 |
| Day's Range | 18.81 - 19.79 |
| 52-Week Range | 8.04 - 25.88 |
| Beta | 2.27 |
About ARCT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ARCT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ARCT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Arcturus Therapeutics has released their quartely earnings
on Aug 11, 2025:
Next Earnings Release
Arcturus Therapeutics Inc. is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 days ago
+29.01%
Arcturus Therapeutics Holdings shares are trading ...
Unlock content with
Pro Subscription
4 days ago
+30.73%
Arcturus Therapeutics Holdings shares are trading higher after the company reported better-than-expected Q2 financial results. Citigroup maintained a Buy rating on the stock and raised its price target from $47 to $49
1 month ago · https://thefly.com
Citi adds 'upside 90-day catalyst watch' on Arcturus Therapeutics08 Jul 09 Jul
